Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Five Duke Researchers Receive NIH Awards (DukeHealth.org)
Sept. 13, 2012
Three researchers at Duke University Medical Center received prestigious young innovators awards from The National Institutes of Health, and two others won competitive grants to study kidney and urologic disease.
Experts Identify Critical Genes Mutated in Stomach Cancer (DukeHealth.org)
Apr. 9, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
Discovery Could Reduce Chemotherapy's Side Effects (DukeHealth.org)
Mar. 11, 2012
A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.
Portion of New Duke Medicine Circle Opens Dec. 5 (http://construction.dukemedicine.org/)
Dec. 1, 2011
As part of preparations for the opening of the new Duke Cancer Center in February, a portion of the new Duke Medicine Circle will open to vehicular traffic on Dec. 5.